搜索筛选:
搜索耗时2.0499秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
Bronchoscopic biopsy for diagnosis of lung cancer in the absence of visible endobronchial abnormalit
[期刊论文] 作者:Hua Zheng,Baohua Lu,Qunhui Wang,Fanbin Hu,Weimin Ding,Baolan Li,,
来源:Oncology and Translational Medicine 年份:2016
Objective Bronchoscopy has been extensively used in the diagnosis of respiratory diseases, and particularly, malignant diseases. However, endoscopists do not no...
Icotinib, an EGFR-TKI, for the treatment of brain metastases in non-small cell lung cancer:a retrosp
[期刊论文] 作者:Qunhui Wang,Hua Zheng,Ying Hu,Baohua Lu,Fanbin Hu,Hongmei Zhang,Baolan Li,,
来源:Oncology and Translational Medicine 年份:2016
Objective Treatment of brain metastases from non-small cell lung cancer(NSCLC) is a challenge because of the poor prognosis. Icotinib is a new type of oral epid...
The expression of vascular endothelial growth factor(VEGF)/endostatin(ES)and VEGF receptor 2(VEGFR2)
[期刊论文] 作者:Yuan Yang,Baohua Lu,Baolan Li,Weiying Li,Mei Jiang,Wentao Yue,Qunhui Wang,Tongmei Zhang,
来源:肿瘤学与转化医学:英文版 年份:2021
Objective The aim of our study was to detect the expression of angiogenesis inhibitory proteins and angiogenesis promotive proteins in the postoperative tumor tissue of non-small cell lung cancer(NSCLC)patients.We also investigated the rela......
The expression of vascular endothelial growth factor (VEGF)/ endostatin (ES) and VEGF receptor 2 (VE
[期刊论文] 作者:Yuan Yang,Baohua Lu,Baolan Li,Weiying Li,Mei Jiang,Wentao Yue,Qunhui Wang,Tongmei Zhang,
来源:肿瘤学与转化医学(英文版) 年份:2021
Objective The aim of our study was to detect the expression of angiogenesis inhibitory proteins and angiogenesis promotive proteins in the postoperative tumor t...
Anlotinib as third-line treatment in patients with refractory advanced non-small cell lung cancer: a
[会议论文] 作者:Baohui Han,Jiang Liyan,Rong Li,Yizhuo Zhao,Kai Li,Baolan Li,Ying Cheng,Jianying Zhou,You Lu,Yuankai Shi,
来源:第十二届中青年呼吸学者论坛 年份:2015
...
Anlotinib as third-line treatment in patients with refractory advanced non-small cell lung cancer: a
[会议论文] 作者:Rong Li,Kai Li,Yizhuo Zhao,Baolan Li,Ying Cheng,Jianying Zhou,You Lu,Yuankai Shi,Zhehai Wang,Jiang Liyan,
来源:第十二届中青年呼吸学者论坛 年份:2015
Background: Anlotinib is a multitargeted tyrosine-kinase inhibitor (TKI).We perform a randomised,double-blind, placebo-controlled, phase 2 trial to assess the efficacy and safety of anlotinib in patie...
相关搜索: